Expansions is the key growth strategy adopted by leading players in the global hemodialysis and peritoneal dialysis market

The key players in the Hemodialysis and Peritoneal dialysis market focus on various strategies such as expansions; product launches and product enhancements; mergers and acquisitions; and partnerships, agreements, and collaborations in order to strengthen their global position. Expansions was the key growth strategy adopted by a majority of the industry players to increase their share in the hemodialysis and peritoneal dialysis market.  

Companies such as Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (U.S.), DaVita Healthcare Partners, Inc. (U.S.), Diaverum Deutschland GmbH (Germany), B. Braun Melsungen AG (Germany), Nipro Corporation (Japan), NxStage Medical, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Nikkiso Co., Ltd. (Japan), and Mar Cor Purification, Inc. (U.S.) majorly adopted this strategy. Apart from geographic expansions, a number of leading players adopted the strategy of product launches and enhancements to develop new and technologically advanced dialysis products and treatment, strengthen their product portfolios, upgrade existing products, and address the unmet needs of end users.

View more detailed TOC @

https://www.marketsandmarkets.com/Market-Reports/dialysis-market-1279.html

As of 2015, Fresenius Medical Care AG & Co. KGaA (Germany) held the leading position in the hemodialysis and peritoneal dialysis market, owing to its strong presence in all the segment of hemodialysis and peritoneal dialysis market. The company focuses on product innovation and product launches as its key business strategies to ensure its growth in the market. It launched new dialysis therapy system–6008 CAREsystem (in May 2016), multiFiltratePRO continuous renal replacement therapy (CRRT) therapy system (in September 2016), sleep•safe harmony (in September 2014), and WetAlert, a wireless wetness detector (in February 2013). In addition, to maintain its leadership position in the dialysis services market, the company has adopted inorganic growth strategies such as partnerships, collaborations, and acquisitions. In February 2016, the company entered into a joint venture partnership with MemorialCare Health System (U.S.). Through this partnership, Fresenius Medical Care operates 15 dialysis clinics in Orange and Los Angeles. Likewise, in May 2013, Fresenius signed a partnership agreement with Apollo Medical Holdings, Inc. (U.S.), to provide integrated healthcare services to ESRD patients.

Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsample.asp?id=1279

DaVita Healthcare Partners, Inc. (U.S.) held the second position in the global hemodialysis and peritoneal dialysis market in 2015. The company’s dominance in the market can be mainly attributed to its strong presence in providing a wide array of renal care services to patients in the U.S. and other countries. It offers dialysis services under three operating segments—Dialysis and Related Lab Services, HCP (HealthCare Partners), and Other Ancillary Services & Strategic Initiatives. As of September 2016, DaVita provided dialysis services to a total of approximately ~750,000 patients at 2,457 outpatient dialysis centers, of which 2,318 are located in the U.S. To sustain its position in the dialysis services market, the company has been concentrating on mergers and acquisitions as its key business strategy. For instance, in May 2016, the company acquired Family Health Care of Central Florida (U.S.). Family Health Care is a primary care group serving in the Orlando metro area in Florida.